KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Long-Term Investments: 2009-2025

Historic Long-Term Investments for Charles River Laboratories International (CRL) over the last 4 years, with Sep 2025 value amounting to $194.6 million.

  • Charles River Laboratories International's Long-Term Investments rose 54.54% to $194.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $194.6 million, marking a year-over-year increase of 54.54%. This contributed to the annual value of $218.3 million for FY2024, which is 10.44% down from last year.
  • Charles River Laboratories International's Long-Term Investments amounted to $194.6 million in Q3 2025, which was down 9.92% from $216.1 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Long-Term Investments registered a high of $311.6 million during Q4 2022, and its lowest value of $60.6 million during Q1 2022.
  • In the last 3 years, Charles River Laboratories International's Long-Term Investments had a median value of $214.0 million in 2025 and averaged $203.4 million.
  • Its Long-Term Investments has fluctuated over the past 5 years, first surged by 715.06% in 2021, then slumped by 60.44% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Long-Term Investments (Quarterly) stood at $201.4 million in 2021, then spiked by 54.75% to $311.6 million in 2022, then fell by 21.76% to $243.8 million in 2023, then fell by 10.44% to $218.3 million in 2024, then soared by 54.54% to $194.6 million in 2025.
  • Its Long-Term Investments was $194.6 million in Q3 2025, compared to $216.1 million in Q2 2025 and $214.0 million in Q1 2025.